YONDELIS (Janssen Products, LP)
Welcome to the PulseAid listing for the YONDELIS drug offered from Janssen Products, LP. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Products, LP |
NON-PROPRIETARY NAME: | Trabectedin |
SUBSTANCE NAME: | TRABECTEDIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-10-23 |
END MARKETING DATE: | 0000-00-00 |
YONDELIS HUMAN PRESCRIPTION DRUG Details:
Item Description | YONDELIS from Janssen Products, LP |
LABELER NAME: | Janssen Products, LP |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.05(mg/mL) |
START MARKETING DATE: | 2015-10-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59676-610_91873b39-8de1-422b-b643-ed5151c60416 |
PRODUCT NDC: | 59676-610 |
APPLICATION NUMBER: | NDA207953 |
Other TRABECTEDIN Pharmaceutical Manufacturers / Labelers: